Queensland Centre for Medical Genomics Adopts Illumina, Inc. Sequencing for Australian ICGC Program
Published: May 29, 2012
SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today announced that the Queensland Centre for Medical Genomics (QCMG), home of Australia’s International Cancer Genomics Consortium program, has established Illumina technology as its core sequencing platform in an expanded facility. The QCMG will replace their fleet of SOLiD/5500 systems with three Illumina HiSeq 2500 systems. This new partnership began in April.